Determinant selection of major histocompatibility complex class I- restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues

The contribution of major histocompatibility complex (MHC) class I- peptide affinity to immunodominance of particular peptide antigens (Ags) in the class I-restricted cytotoxic T lymphocyte (CTL) response is not clearly established. Therefore, we have compared the H-2Kb- restricted binding and presentation of the immunodominant ovalbumin (OVA)257-264 (SIINFEKL) determinant to that of a subdominant OVA determinant OVA55-62 (KVVRFDKL). Immunodominance of OVA257-264 was not attributable to the specific T cell repertoire but correlated instead with more efficient Ag presentation. This enhanced Ag presentation could be accounted for by the higher affinity of Kb/OVA257-264 compared with Kb/OVA55-62 despite the presence of a conserved Kb-binding motif in both peptides. Kinetic binding studies using purified soluble H-2Kb molecules (Kbs) and biosensor techniques indicated that the Kon for association of OVA257-264-C6 and Kbs at 25 degrees C was integral of 10- fold faster (5.9 x 10(3) M-1 s-1 versus 6.5 x 10(2) M-1 s-1), and the Koff approximately twofold slower (9.1 x 10(-6) s-1 versus 1.6 x 10(-5) s-1), than the rate constants for interaction of OVA55-62-C6 and Kbs. The association of these peptides with Kb was significantly influenced by multiple residues at presumed nonanchor sites within the peptide sequence. The contribution of each peptide residue to Kb-binding was dependent upon the sequence context and the summed contributions were not additive. Thus the affinity of MHC class I-peptide binding is a critical factor controlling presentation of peptide Ag and immunodominance in the class I-restricted CTL response.

[1]  M. Bevan,et al.  Dissection of major histocompatibility complex (MHC) and T cell receptor contact residues in a Kb‐restricted ovalbumin peptide and an assessment of the predictive power of MHC‐binding motifs , 1992, European journal of immunology.

[2]  J. McCluskey,et al.  Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen. , 1993, Journal of immunological methods.

[3]  D. R. Madden,et al.  Identification of self peptides bound to purified HLA-B27 , 1991, Nature.

[4]  S. Nathenson,et al.  The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Peter Walden,et al.  Exact prediction of a natural T cell epitope , 1991, European journal of immunology.

[6]  J. Frelinger,et al.  Evidence of widespread binding of HLA class I molecules to peptides , 1990, The Journal of experimental medicine.

[7]  R. Germain,et al.  Peptide and beta 2-microglobulin regulation of cell surface MHC class I conformation and expression. , 1992, Journal of immunology.

[8]  P. Parham,et al.  Direct binding of influenza peptides to class I HLA molecules , 1989, Nature.

[9]  M. Bekoff,et al.  Relative contribution of "determinant selection" and "holes in the T-cell repertoire" to T-cell responses. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[10]  D. Finley,et al.  MHC-linked LMP gene products specifically alter peptidase activities of the proteasome , 1993, Nature.

[11]  J. McCluskey,et al.  Changes at peptide residues buried in the major histocompatibility complex (MHC) class I binding cleft influence T cell recognition: a possible role for indirect conformational alterations in the MHC class I or bound peptide in determining T cell recognition , 1993, The Journal of experimental medicine.

[12]  C. DeLisi,et al.  An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. A. Peterson,et al.  Quantitation of peptide anchor residue contributions to class I major histocompatibility complex molecule binding. , 1993, The Journal of biological chemistry.

[14]  William S. Lane,et al.  Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.

[15]  W. Lafuse,et al.  Detection of hybrid (combinatorial) Ia antigens using parent anti-F1 sera. , 1981, Journal of immunology.

[16]  E. Pamer,et al.  Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes , 1991, Nature.

[17]  R. Karlsson,et al.  Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. , 1991, BioTechniques.

[18]  F. Carbone,et al.  The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb‐restricted ovalbumin determinant , 1990, European journal of immunology.

[19]  J. Berzofsky,et al.  The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition. , 1993, Journal of immunology.

[20]  E. Coligan.  Current protocols in immunology , 1991 .

[21]  J. Casanova,et al.  Real‐time measurement of antigenic peptide binding to empty and preloaded single‐chain major histocompatibility complex class I molecules , 1993, European journal of immunology.

[22]  B. Moss,et al.  Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins. High frequency of nonresponder MHC class I alleles , 1988, The Journal of experimental medicine.

[23]  A. Casrouge,et al.  Dissociation of the peptide-MHC class I complex limits the binding rate of exogenous peptide. , 1993, Journal of Immunology.

[24]  J. Sidney,et al.  Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules , 1993, Cell.

[25]  K. Ozato,et al.  Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2b haplotype reveal genetic control of isotype expression. , 1981, Journal of immunology.

[26]  E. Appella,et al.  Mechanisms influencing the immunodominance of T cell determinants , 1988, The Journal of experimental medicine.

[27]  Hidde L. Ploegh,et al.  Empty MHC class I molecules come out in the cold , 1990, Nature.

[28]  P. A. Peterson,et al.  Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.

[29]  H. Rammensee,et al.  Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.

[30]  E. Padlan,et al.  Endogenous peptides of a soluble major histocompatibility complex class I molecule, H-2Lds: sequence motif, quantitative binding, and molecular modeling of the complex , 1992, The Journal of experimental medicine.

[31]  D. Wiley,et al.  Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.

[32]  J. Monaco,et al.  MHC class II region encoding proteins related to the muKidrug resistance family of transmembrane transporters , 1990, Nature.

[33]  M. Bevan,et al.  Class I-restricted processing and presentation of exogenous cell- associated antigen in vivo , 1990, The Journal of experimental medicine.

[34]  A. Townsend,et al.  Restoration of antigen presentation to the mutant cell line RMA-S by an MHC-linked transporter , 1991, Nature.

[35]  Georg Greiner,et al.  Preferred size of peptides that bind to H‐2 Kb is sequence dependent , 1992, European journal of immunology.

[36]  A Sette,et al.  The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides , 1987, Science.

[37]  K. Parker,et al.  Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. , 1994, Journal of immunology.

[38]  S. Tonegawa,et al.  TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective , 1993, Cell.

[39]  K. Rock,et al.  Chemical cross-linking of class I molecules on cells creates receptive peptide binding sites. , 1992, Journal of immunology.

[40]  Kendall A. Smith,et al.  T cell growth factor: parameters of production and a quantitative microassay for activity. , 1978, Journal of immunology.

[41]  J. Bluestone,et al.  Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition , 1992, The Journal of experimental medicine.

[42]  M. Bevan,et al.  Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.

[43]  T. Elliott,et al.  Assembly of MHC class I molecules analyzed in vitro , 1990, Cell.

[44]  J. Sidney,et al.  MHC class II molecules bind indiscriminately self and non-self peptide homologs: effect on the immunogenicity of non-self peptides. , 1993, International immunology.

[45]  J. Levy,et al.  Analysis of physical interactions between peptides and HLA molecules and application to the detection of human immunodeficiency virus 1 antigenic peptides , 1990, The Journal of experimental medicine.

[46]  H. Mario Geysen,et al.  The simultaneous multiple production of solution phase peptides; assessment of the geysen method of simultaneous peptide synthesis. , 1990 .

[47]  J. Slot,et al.  Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi , 1992, Nature.

[48]  M R Jackson,et al.  In vitro peptide binding to soluble empty class I major histocompatibility complex molecules isolated from transfected Drosophila melanogaster cells. , 1992, The Journal of biological chemistry.

[49]  D. Margulies,et al.  Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. , 1993, The Journal of biological chemistry.

[50]  M Hoffman,et al.  Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif. , 1993, Journal of immunology.

[51]  J. D. Dal Porto,et al.  Major histocompatibility complex conformational epitopes are peptide specific , 1992, The Journal of experimental medicine.

[52]  Timothy E. Elliott,et al.  The binding affinity and dissociation rates of peptides for class I major histocompatibility complex molecules , 1991, European journal of immunology.

[53]  P. Marrack,et al.  Reactivity of V beta 17a+ CD8+ T cell hybrids. Analysis using a new CD8+ T cell fusion partner , 1989, The Journal of experimental medicine.

[54]  D. Margulies,et al.  MHC Class I/peptide interactions: Binding specificity and kinetics , 1993, Journal of molecular recognition : JMR.

[55]  P. Kourilsky,et al.  Specificity of peptide presentation by a set of hybrid mouse class I MHC molecules , 1987, Nature.

[56]  S. Rodda,et al.  T cell receptor alpha-chain pairing determines the specificity of residue 262 within the Kb-restricted, ovalbumin257-264 determinant. , 1992, International immunology.

[57]  B. Moss,et al.  Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes , 1986, Journal of virology.

[58]  I. Wada,et al.  The p88 molecular chaperone is identical to the endoplasmic reticulum membrane protein, calnexin. , 1992, The Journal of biological chemistry.

[59]  C. Harding.  Electroporation of exogenous antigen into the cytosol for antigen processing and class I major histocompatibility complex (MHC) presentation: weak base amines and hypothermia (18°C) inhibit the class I MHC processing pathway , 1992, European journal of immunology.

[60]  M. Mamula.  The inability to process a self-peptide allows autoreactive T cells to escape tolerance , 1993, The Journal of experimental medicine.

[61]  M. Bevan,et al.  Peptide variants reveal how antibodies recognize major histocompatibility complex class I , 1993, European journal of immunology.

[62]  T. Elliott,et al.  Assembly and function of the two ABC transporter proteins encoded in the human major histocompatibility complex , 1992, Nature.

[63]  J. Bonifacino,et al.  Brefeldin A implicates egress from endoplasmic reticulum in class I restricted antigen presentation , 1989, Nature.

[64]  P. A. Peterson,et al.  Crystal structures of two viral peptides in complex with murine MHC class I H-2Kb. , 1994, Science.

[65]  E. Degen,et al.  Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2- microglobulin and peptide , 1992, The Journal of experimental medicine.

[66]  H. Ljunggren,et al.  Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.

[67]  M. Luscher,et al.  Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis , 1991, Nature.

[68]  J. Coligan,et al.  Inhibition of an allospecific T cell hybridoma by soluble class I proteins and peptides: Estimation of the affinity of a T cell receptor for MHC , 1989, Cell.

[69]  J. Neefjes,et al.  Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.